NovoCure Limited —— 季度财务数据 (NASDAQ:NVCR) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -3.45 M-35.66 M-15.94 M20.57 M-18 M -49.03 M 投资活动产生的现金 -22.21 M-6.47 M35.99 M71.44 M336.33 M 437.28 M 融资活动产生的现金 2.69 M5.25 M2.39 M100.52 M-559.49 M -451.34 M 自由现金流 -12.39 M-46.28 M-21.42 M14.92 M-22.9 M -75.68 M

新闻

Humacyte, Inc. (HUMA) Reports Q4 Loss, Misses Revenue Estimates

Novocure在Leerink会议上:癌症治疗领域的战略增长

Novocure at Leerink Conference: Strategic Growth in Cancer Treatment

Novocure's Optune Lua Gets Japan Reimbursement for NSCLC Treatment

NovoCure (NVCR) Reliance on International Sales: What Investors Need to Know

Novocure获日本批准Optune Lua设备纳入医保报销

Novocure gains Japan reimbursement for Optune Lua device

NovoCure (NVCR) Reports Q4 Loss, Beats Revenue Estimates

NovoCure Limited (NVCR) Q4 2025 Earnings Call Transcript

Novocure Ltd earnings beat by $0.19, revenue topped estimates

Netflix and Palantir among market cap stock movers on Wednesday

Novocure财报即将公布:胰腺癌产品上市成焦点